DNA and Synthetic Conjugate Vaccines

Conjugate antibodies, made up of a bacterial polysaccharide antigen cross-connected to a bacterial protein, are among the best immunizations accessible today to avert bacterial diseases, for example, pneumococcal and meningococcal contaminations. Conjugate antibodies against bacterial pathogens with a substantial number of serotypes, for example, Streptococcus pneumoniae, generally cover just a few the current strains. Another recombinant DNA-based assembling innovation has been created to avert genuine bacterial diseases. This innovation can possibly prompt antibodies against unmanageable pathogens, for example, S. aureus and Shigella species and to rearrange and enhance the proficiency of creating complex conjugate antibodies.

 

  • Adjuvant
  • DNA vaccination
  • Prime-boost Vaccination
  • Polysaccharide Chemistry and Glyco-Conjugate Vaccines
  • Reverse Vaccinology
  • DNA Immunization
  • DNA Plasmid
  • Pneumococcal Conjugate Vaccine

Related Conference of DNA and Synthetic Conjugate Vaccines

March 18-19, 2021

3rd World Conference on Vaccine and Immunology

Dubai, UAE
April 05-05, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
May 03-04, 2021

International Online Conference on Immunology

New York, USA
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 12-13, 2021

International Conference on Vaccine and Vaccine research

Manila, Philippines
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia
October 14-15, 2021

11th International Conference on Bacteriology and Infectious Diseases

Cape Town, South Africa

DNA and Synthetic Conjugate Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in